precision cancer care
NAVICAN is bridging the gap
between testing and treatment.
Because all cancer patients deserve access to the best care.
today ’s reality
Too many people don’t get the precision therapy they need. We can do better.
100s of thousands of metastatic cancer patients
10s of thousands of genomics tests performed annually
Only a small percentage actually receive a change to targeted therapy
Source: 2016 data analysis and primary market research
NAVICAN is the essential bridge to help everyone access precision cancer therapy.
By prioritizing treatment recommendations and streamlining the process, we help oncologists help patients live longer, more fulfilling lives. This way, patients can spend less time worrying about their treatment and have more quality
time with those who matter most.
we can help
NAVICAN, an Intermountain Healthcare company, offers TheraMap ™ – a comprehensive end-to-end solution to help both oncologists and patients harness the power of precision genomics, clinical analytics, and patient services for optimal cancer management.
Developed through years of experience and clinical best practices of Intermountain Healthcare, TheraMap gives oncologists more confidence in determining actionable cancer gene mutations. By matching your patient with prioritized treatment options or appropriate clinical trials, we can help you deliver a better outcome and reduce costs.
-
Sample acquisition
simplifying
shipment -
Sequencing & bioinformatics
testing -
Molecular tumor board
guiding
decisions -
Therapy access
navigating
treatment -
Follow through
improving
outcomes
When TheraMap is ordered by an oncologist, the process starts by securing the tumor specimen for processing. With all the logistics and paperwork taken care of, it’s easier for oncologists to focus on what’s important: caring for their patients.
Utilizing state-of-the-art next-generation sequencing, additional molecular methods, and proprietary data analytics, Precision Genomics at Intermountain Healthcare identifies all clinically relevant cancer mutations. This comprehensive tumor profile serves as the foundation for Intermountain’s molecular tumor board to analyze and prioritize treatment options.
Click here to download the technical details and specific gene list.
Getting results is one thing. Knowing how to interpret them is another. NAVICAN provides access to a group of key opinion leaders and experts in the clinical field with multi-institutional, multi-disciplinary backgrounds. These experts will provide a firm recommendation for treatment with one specific therapy highlighted and others stack ranked below it.
Of course, treatment decisions should always be made by the oncologist and the individual patient, but we can help take much of the uncertainty out of the equation.
While other companies stop at genomic profiling, NAVICAN provides experienced treatment navigators through Intermountain Healthcare to facilitate drug or clinical trial access so that patients can get the precision therapy they need as soon as possible.
Treatment navigators are there every step of the way for both medical staff and patients. They guide the entire process: accessing therapy, taking care of paperwork, submitting insurance claims, and facilitating financial counseling.
We’re committed to caring for patients. Our job isn’t done until we’ve made an impact on each of the patients we serve.
leadership
board of directors
I have a passion for the field of oncology and I feel privileged that I can be part of something bigger: helping people live the healthiest lives possible®.
I joined Intermountain Healthcare in June 2016, spinning off NAVICAN in October 2016. I previously served in senior roles at Genmark Diagnostics, Gen-Probe, Roche Diagnostics, and Ventana Medical Systems here in the United States and in Europe. I graduated from Friedrich Haecker School in Germany with a degree in electrical engineering.
My leadership philosophy is grounded in collective intelligence, goal orientation, and personal accountability. I love building environments that are energetic, ambitious, and challenging while providing room for fairness, tolerance, and creativity.
With NAVICAN, I can:
improve patients ’ lives
I joined Intermountain Healthcare—NAVICAN’s parent company—in 2013, with the goal of instituting personalized cancer medicine by identifying and targeting DNA abnormalities.
I received an M.D. as well as a Ph.D. in Oncological Science from the University of Utah. I completed postdoctoral and fellowship training at Stanford University. I’m a Board Certified Medical Oncologist and a member of the American Society of Clinical Oncology and the American Association of Cancer Researchers.
I have enjoyed the opportunity of presenting at international conferences, and have had manuscripts published in various peer-reviewed journals, including Nature Medicine, Genome Biology, and the Journal of Clinical Oncology. I currently serve as an Associate Editor for the Journal of Clinical Oncology-Precision Oncology.
With NAVICAN, I can:
change lives every day
I lead all IT and informatics functions for NAVICAN, including development and support of the core reporting pipeline.
I bring more than 18 years of senior information technology leadership roles in the health and life sciences industry. Prior to joining NAVICAN, I worked with Human Longevity, Inc., RainTree Oncology, Illumina, and Amgen.
I earned my Bachelor’s degree in Computer Information Systems and Master’s degree in Business Administration from California Lutheran University.
With NAVICAN, I can:
innovate to advance cancer care
I’m passionate about building an exceptional team and creating an organization in which we will all thrive and deliver on the promise of Precision Cancer Care.
My background includes more than 20 years of experience contributing to global, fast-paced, growing biotechnology and high technology organizations. I have held various human resources leadership positions at Cytori Therapeutics, Millennium Health, Hologic, Gen-Probe, Biogen Idec, Memec, and Accenture.
I earned my Bachelor’s degree in Human Biology at Stanford University and my Master’s degree in Global Human Resources Leadership from Rutgers University.
With NAVICAN, I can:
help people achieve their dreams
I lead all Finance, Compliance, and Facilities functions at NAVICAN.
Previously, I worked in senior finance leadership roles including as CFO at a national education company, CFO at a consumer goods company, and Director of FP&A for a molecular diagnostics company. I also worked as a strategy consultant with McKinsey & Company and an investment banker with Lazard Middle Market.
I earned my MBA from Columbia Business School and a BS in Finance from the University of Economics in Prague.
With NAVICAN, I can:
help cancer patients every day
I’m driven by a desire to work harder and do more to support the global cancer community. I joined NAVICAN in January 2017 to lead all functions related to sales, marketing, and customer/patient services. I am confident we will make a difference.
I previously served as the Head of Sales and Sales Operations for Genoptix Medical Laboratory focusing on testing for hematology patients. Prior to my experience in cancer diagnostics, I worked in oncology pharmaceutical sales for Ortho Biotech, a division of Johnson & Johnson.
My Bachelor’s degree is in Communications from the College of Charleston, and my MBA is in International Business from Florida Atlantic University.
With NAVICAN, I can:
drive access to the best in cancer care
I’m focused on providing legal support for Navican’s efforts to provide better information to oncologists and their patients.
My background includes extensive and varied experience advising molecular diagnostic companies. I served as general counsel for Gen-Probe Inc. from 1997 to 2012 while the company grew revenues from $75 million to approximately $600 million annually, and subsequently served as general counsel for Sequenom, Inc., a CLIA laboratory-based provider of prenatal genetic testing.
I earned my Bachelor’s of Science in Commerce and my Juris Doctor degree from the University of Virginia.
With NAVICAN, I can:
improve cancer patients ’ quality of life
Helping more people effectively get access to the precision therapy they need is my passion.
I joined Intermountain Healthcare—NAVICAN’s parent company—in 2003. I’m responsible for all financial, insurance/health plans, and information systems operations. More recently, I’ve led the planning and leadership of Intermountain’s new business development and innovation strategies.
Over my career, I’ve held senior positions at Methodist Hospital System and Memorial Hermann Healthcare System, both in Houston. I was also a partner in Ernst & Young’s office there, where I spent 16 years, specializing in healthcare.
With NAVICAN, I can:
help people live the healthiest lives possible
My experience in the medial and diagnostics fields spans nearly four decades.
I’m currently the CEO and founder of Octave Bioscience, an early stage molecular diagnostics company focused on neurodegenerative diseases and conditions.
Recent career highlights include serving as President and CEO of Crescendo Bioscience, a specialty diagnostics company focused on autoimmune and inflammatory diseases managed by rheumatologists and President of Alpha BioPartners, a strategic consulting firm for early stage biotechnology companies.
With NAVICAN, I can:
make life better for all
I have a passion for the field of oncology and I feel privileged that I can be part of something bigger: helping people live the healthiest lives possible®.
I joined Intermountain Healthcare in June 2016, spinning off NAVICAN in October 2016. I previously served in senior roles at Genmark Diagnostics, Gen-Probe, Roche Diagnostics, and Ventana Medical Systems here in the United States and in Europe. I graduated from Friedrich Haecker School in Germany with a degree in electrical engineering.
My leadership philosophy is grounded in collective intelligence, goal orientation, and personal accountability. I love building environments that are energetic, ambitious, and challenging while providing room for fairness, tolerance, and creativity.
With NAVICAN, I can:
improve patients ’ lives
we can change lives
We’re driven by an impatience to make more precision therapy options available to more cancer patients. If you have a passion to help people, a desire to grow, and you excel at what you do, join us at NAVICAN to make a positive impact on the world.
trending topics
Learn more about exciting new developments in precision cancer care.
